2021 Senate Bill 641

Require Medicaid providers adopt specified sickle cell practices

Introduced in the Senate

Sept. 15, 2021

Introduced by Sen. Jim Ananich (D-27)

To require the Medicaid managed care organizations contracted by the state to operate this program to adopt and provide various “sickle cell disease care management and care” practices. Among other things these would have to “develop a sickle cell disease-focused comprehensive assessment tool to screen for comorbidities…including disease-modifying medications and pain management, psychosocial history, barriers to accessing or completing treatments, social supports, other care coordinators working with the member, community resources being used or needed, quality of life, and personal preferences for engagement with a care coordinator”.

Referred to the Committee on Health Policy and Human Services

June 23, 2022

Reported without amendment

With the recommendation that the substitute (S-3) be adopted and that the bill then pass.

Sept. 28, 2022

Passed in the Senate 35 to 0 (details)

Received in the House

Sept. 28, 2022

Referred to the Committee on Health Policy